A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Lawsuits against the companies began piling up in both state and federal courts after the US Food and Drug Administration in ...

The need for antiemetic drugs, which help prevent or relieve nausea and vomiting, is growing for several reasons. A key factor is the rising incidence of conditions and treatments that cause these ...

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

German family-owned pharma major Boehringer Ingelheim and USA-based Circle Pharma (have entered into a research collaboration and license agreement with the shared goal to develop a first-in-class ...

The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...

The rise in research and development activities in schizophrenia treatment is driving market growth by fostering the development of innovative therapies, including novel antipsychotics and ...

Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

“Earlier this year, our EDAPT platform received strong external validation when Boehringer Ingelheim decided to exercise ... From its headquarters in the Netherlands and offices in Germany, USA and ...

The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.